CIK 0001509745 · Non-accelerated filer<br>Smaller reporting company
CYPHERPUNK TECHNOLOGIES INC.
Sign in to watch- Ticker
- CYPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 274412575
- Phone
- 617 252 4343
- Business address
- 47 THORNDIKE STREET, SUITE B1-1, CAMBRIDGE, MA, 02142
- Former names
- LEAP THERAPEUTICS, INC., Dekkun Corp
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Delisting notice
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Exit or restructuring costs · Executive or director change · Shareholder vote results · Other events
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Option exercise CEO,CFO,Pres.,GC,Treas.&Sec. acquired 32,500 shares (option exercise)
- 4 Shares withheld for taxes VP, Head of Reg Affairs/Qual gave up 6,604 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 6,604 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 7,797 shares (to pay taxes)
- 4 Option exercise Chief Manufacturing Officer acquired 22,500 shares (option exercise)
Page 6 of 32 · 623 filings